LONGEVITY AND METABOLIC CLINICS
Patient acquisition for cash-pay longevity clinics.
Meta and Google both treat named GLP-1 medications as restricted pharmaceutical content. Campaigns that ignore that lose the ad account, not just the ad. We build search capture and intake that work inside the policy and hold the consultation the same day.
The constraint is the policy, not the budget.
A metabolic, hormone or cellular program sells at a price that carries paid search comfortably. Two things limit it instead. Both ad networks restrict content naming GLP-1 medications, and a consultation request has a shelf life measured in hours rather than days. Spend that clears policy and then lands in a voicemail queue converts no better than spend that never ran.
When cost per consultation climbs, it is usually one of three things.
- Restricted term exposure. Bidding on protected drug names, or running creative that states a physical outcome, puts the ad account itself at risk rather than the individual ad.
- Suppressed event data. Medical privacy settings and browser restrictions stop consultation events reaching the ad network, so the network bids against a partial picture of who converted.
- Intake delay. The request arrives and waits for a staff member. Cost per consultation holds steady inside the ad platform while cost per booked patient moves the other way.
Three different problems. Changing the ads only fixes one of them.
Three ways to open the constraint.
- Category search, not drug search. Bid on the condition, the program and the consultation rather than the molecule. The intent is close to identical and the ad account is not exposed to a policy review.
- Server-side event capture. Pass consultation events to the network through the Conversions API from your own server, with patient identifiers kept separate from the advertising pixel, so the network optimizes on data that actually arrived.
- Same-day intake. Route every request into a booking step that runs without a staff member in the loop, so the consultation is held while the prospect is still deciding.
Which one you need depends on the diagnosis, and the diagnosis comes first.
The closest work we can show you.
-
LASIK PRACTICE
4x
$252K in revenue on $63K in marketing spend.
63 new patients in six months, on $63,088 in marketing spend.
Read the case
-
HOSPITAL ADOPTION
6.4x
Annual account goal exceeded by Q3.
Tracked inquiries gave reps evidence of demand. The 20-account annual goal was passed before Q4.
Read the case
-
15+
YEARS OF INDUSTRY EXPERTISE
-
$30M+
GENERATED FOR CLIENTS
-
120+
AD ACCOUNTS MANAGED AT ONCE
Before we start.
What have you run in this category?
The closest engagement on our record is a LASIK practice: 63 new patients in six months, $252,200 in patient revenue on $63,088 in marketing spend. Cash-pay, high ticket, local, bought through search and automated follow-up. The case study carries the full numbers.
Will you bid on semaglutide or tirzepatide?
No. Named drug terms are restricted on both networks, and bidding on them puts the ad account at risk rather than the campaign. We bid on the program, the condition and the consultation instead.
What ad budget do I need?
At least $5,000/month in active ad spend, paid directly to platforms and separate from our management fee.
Do you build the booking system?
We audit the path from ad to held consultation and say where it breaks. Building or changing the scheduling and intake tooling is agreed in the scope.
Who actually runs my campaigns?
Rachael Leigh handles your strategy and execution. We never hand your budget over to junior buyers.
Let's fix your ROI.
Skip the vanity metrics and the guesswork. Work with a performance marketing partner you can trust to scale your business, profitably.
Maximize My ROI